(Q45601707)

14 December 2017

title

Treatment of hepatitis C virus infection in patients of northern India (English)

1 reference

14 December 2017

1 reference

1 reference

2

Subrat Kumar Panda

1 reference

14 December 2017

Sidhartha Hazari

1

1 reference

14 December 2017

Siddharth Datta Gupta

3

1 reference

14 December 2017

Yogesh Batra

4

1 reference

14 December 2017

Rajbir Singh

5

1 reference

14 December 2017

Subrat Kumar Acharya

6

1 reference

14 December 2017

publication date

1 September 2004

1 reference

Journal of Gastroenterology and Hepatology

14 December 2017

published in

1 reference

14 December 2017

volume

19

1 reference

14 December 2017

issue

9

1 reference

14 December 2017

page(s)

1058-1065

1 reference

Hepatitis C virus infection in the general population: a community-based study in West Bengal, India

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Genotype determination of hepatitis C virus from northern India: identification of a new subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Chronic hepatitis C infection: influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

Early predictors of response to treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03405.X

10.1111/J.1440-1746.2004.03405.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference